Table 3.
Neuraxis Level | Disorder | Examples of Salient Antibodies |
---|---|---|
Eye | Autoimmune retinopathy, optic neuropathy | CRMP-5-IgG, NMO-IgG |
Cerebral cortex | Limbic encephalitis, encephalitides presenting primarily with seizures or cognitive dysfunction, myoclonus | ANNA-1, VGKC complex Ab, NMDA receptor Ab |
Diencephalon | Hypothalamic dysfunction, sleep disorders | Ma1/Ma2 Ab |
Basal ganglia | Chorea, dystonia | CRMP-5 IgG |
Cerebellum | Cerebellar ataxia/degeneration | PCA-1, P/Q type calcium channel Ab |
Brain stem | Brain stem encephalitis, jaw dystonia Stiff-man phenomena (including stiffness, spasms, exaggerated startle, if widespread referred to as progressive encephalomyelitis with rigidity and myoclonus [PERM]), opsoclonus–myoclonus syndrome | ANNA-2, Ma1/Ma2, glycine receptor ab |
Cranial nerves | Special senses, bulbar, motor neuropathies | ANNA-1, CRMP-5 IgG |
Spinal cord | Myelopathy, myoclonus Stiff-man phenomena | CRMP-5 IgG, NMO-IgG, GAD65 Ab |
Peripheral somatic nerves and ganglia | Sensory neuronopathy, sensorimotor neuropathies | ANNA-1, VGKC complex Ab |
Neuromuscular junction | Lambert-Eaton syndrome, Myasthenia gravis | P/Q-type calcium channel Ab, muscle AChR Ab |
Muscle | Polymyositis dermatomyositis, necrotizing myopathy | Jo1 Ab, SRP-54 Ab |
Autonomic and enteric nervous system | Dysautonomias (pandysautonomia or limited dysautonomia, which includes gastrointestinal dysmotilities) | ANNA-1, alpha-3 ganglionic AChR |
Abbreviations: AchR, acetylcholine receptor; ANNA, antineuronal nuclear antibody; CRMP5, collapsin-response mediator protein 5; PCA-1, purkinje cell cytoplasmic antibody type 1; VGKC, voltage-gated potassium channel; NMDA, N-methyl-d-aspartate; GABA-B, gamma-aminobutyric acid-B; Jo-1 Abs, anti-histidyl-tRNA synthetase Abs; NMO, neuromyelitis optica; IgG, immunoglobulin G; PERM=progressive encephalomyelitis with rigidity and myoclonus; SRP=signal recognition particle.
aMany of these disorders can be multifocal.